Viking Fund Management LLC Amgen Inc Transaction History

Viking Fund Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$255.7 - $288.46 $1.79 Million - $2.02 Million	7,000 New	7,000 $2.02 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $1.17 Million - $1.3 Million	-5,000 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $197,810 - $242,740	-1,000 Reduced 16.67%	5,000 $1.18 Million
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $455,600 - $604,250	-2,500 Reduced 29.41%	6,000 $1.22 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $283,815 - $364,800	-1,500 Reduced 15.0%	8,500 $2.05 Million
Q2 2019 Jul 16, 2019	BUY	$166.7 - $195.41 $1.67 Million - $1.95 Million	10,000 New	10,000 $1.84 Million
Q4 2017 Jan 19, 2018	SELL	$168.79 - $188.59 $1.43 Million - $1.6 Million	-8,500 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $1.42 Million - $1.62 Million	8,500	8,500 $1.59 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Viking Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Viking Fund Management LLC with notifications on news.